Quantum Biopharma Ltd. Class B Subordinate Voting Shares
6.96
USD
Gesponsert
-0.30
-4.13%
09. Jan., 15:58 UTC -5
Geschlossen
Nach-Markt
7.13
+0.17
+2.44%
QNTM Ergebnisberichte
Positives Überraschungsverhältnis
QNTM übertreffen die 2 der letzten 5Schätzungen.
40%
Nächster Bericht
Datum des nächsten Berichts
26. März 2026
Estimate forQ4 25(Revenue/ EPS)
--
/
--
Implizierte Änderung vonQ3 25(Revenue/ EPS)
--
/
--
Implizierte Änderung vonQ4 24(Revenue/ EPS)
--
/
--
Quantum Biopharma Ltd. Class B Subordinate Voting Shares earnings per share and revenue
On 07. Nov. 2025, QNTM reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Quantum Biopharma Ltd. Class B Subordinate Voting Shares's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Quantum Biopharma Ltd. Class B Subordinate Voting Shares reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Quantum Biopharma Ltd. Class B Subordinate Voting Shares's Q3 2025 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Quantum Biopharma Ltd. Class B Subordinate Voting Shares expected to report next?
The next earning report is scheduled for 26. März 2026.
What are the forecasts for Quantum Biopharma Ltd. Class B Subordinate Voting Shares's next earnings report?
Based on --
analysts, Quantum Biopharma Ltd. Class B Subordinate Voting Shares is expected to report EPS of -- and revenue of -- for Q4 2025.